Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,713 | -6,845 | -4,962 | -40,507 | -20,707 |
| Depreciation Amortization | N/A | N/A | N/A | 337 | 169 |
| Accounts receivable | 7 | 39 | 45 | N/A | N/A |
| Accounts payable and accrued liabilities | 368 | 87 | 330 | -121 | 598 |
| Other Working Capital | 305 | 100 | 269 | 1,112 | 53 |
| Other Operating Activity | 595 | 3,477 | 2,273 | 2,674 | 1,112 |
| Operating Cash Flow | $-438 | $-3,142 | $-2,046 | $-36,505 | $-18,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 0 | -14,675 | 8,317 |
| PPE Investments | N/A | N/A | N/A | -27 | N/A |
| Investing Cash Flow | $N/A | $N/A | $0 | $-14,702 | $8,317 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 750 | 3,300 | 1,950 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -4,624 | -2,311 |
| Common Stock Issued | N/A | 0 | N/A | 41,810 | N/A |
| Financing Cash Flow | $750 | $3,300 | $1,950 | $37,186 | $-2,311 |
| Beginning Cash Position | 306 | 148 | 148 | 46,024 | 46,024 |
| End Cash Position | 618 | 306 | 53 | 32,003 | 33,255 |
| Net Cash Flow | $312 | $158 | $-96 | $-14,021 | $-12,769 |
| Free Cash Flow | |||||
| Operating Cash Flow | -438 | -3,142 | -2,046 | -36,505 | -18,775 |
| Capital Expenditure | N/A | N/A | 0 | -27 | N/A |
| Free Cash Flow | -438 | -3,142 | -2,046 | -36,532 | -18,775 |